Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy
NCT05249543
Summary
The primary aim of the pilot study is to investigate the feasibility of conducting a randomized controlled trial (RCT) comparing the effects of transdiagnostic and diagnosis-specific cognitive-behavioral therapy (CBT) for patients with anxiety disorders in routine psychiatric outpatient care in Stockholm, Sweden. It is hypothesized that an RCT is feasible in terms of recruitment, retention, therapist competence and adherence to treatments, and that the treatments are well received by participants.
Eligibility
Inclusion Criteria: * 18-65 years of age, * Being able to speak Swedish without interpreter support, * A principal diagnosis of panic disorder, generalized anxiety disorder, social anxiety disorder, obsessive-compulsive disorder, or posttraumatic stress disorder, and * Pharmacological treatment (if any) that is stable six weeks prior to treatment start Exclusion Criteria: * Current diagnosis of psychotic disorder, bipolar disorder, or moderate to severe substance use disorder, * Moderate to severe risk of suicide, * Psychiatric, somatic, or social problems which require other management or intervention than cognitive-behavioral therapy, and * Other simultaneous psychological treatment
Conditions6
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05249543